Southern Farm Bureau Life Insurance’s ARK Genomic Revolution ETF ARKG Stock Holding History

Southern Farm Bureau Life Insurance’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-103,930	Closed	-$4.77M	–	31
2022 Q1	$4.77M	Hold	103,930	–	–	0.67%	19
2021 Q4	$6.37M	Hold	103,930	–	–	0.87%	17
2021 Q3	$7.77M	Hold	103,930	–	–	1.14%	17
2021 Q2	$9.61M	Buy	103,930 +8,900	+9%	+$757K	1.32%	18
2021 Q1	$8.43M	Sell	95,030 -6,200	-6%	-$615K	1.42%	18
2020 Q4	$9.44M	Buy	+101,230	New	+$8.07M	2.05%	16

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Southern Farm Bureau Life Insurance's ARKG Position: Q2 2022 in Review

Southern Farm Bureau Life Insurance sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 103,930 shares — an estimated $4.77M sold.

Southern Farm Bureau Life Insurance first reported a position in ARKG in Q4 2020 and held it in 6 quarters. The position peaked at $9.61M in Q2 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Southern Farm Bureau Life Insurance reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Southern Farm Bureau Life Insurance sold 103,930 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $4.77M.
Southern Farm Bureau Life Insurance first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 6 quarters.
Southern Farm Bureau Life Insurance's ARK Genomic Revolution ETF position peaked at $9.61M in Q2 2021.
334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Southern Farm Bureau Life Insurance's 13F filing for Q2 2022, filed 1 Aug 2022.